United States · Markets & Finance · Morningstar
Transcenta Therapeutics Announces Appointment of Ms. Jennie Ma as Chief Financial Officer
Transcenta Therapeutics (HKEX: 06628) today announced that its Board of Directors has approved the appointment of Ms. Jennie Ma as Chief Financial Officer (CFO) of the Company. In…
Read the full article on Morningstar Sign in to saveMediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.morningstar.com)




